Jane Mattei, MD, PhD
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Jane Mattei, MD, PhD
Jane Mattei, MD, is an assistant professor in the Division of Hematology and Medical Oncology and a melanoma and skin cancer specialist. After earning her medical and doctorate degrees and completing her residency, she concluded her fellowship in medical oncology in South Brazil. She completed a melanoma oncology fellowship where she received specialized clinical training in the disease at The University of Texas MD Anderson Cancer Center.
Gender
- Female
Languages Spoken
- English
- Portuguese
-
Credentials
Credentials
Positions
- Assistant Professor of Medicine, University of Texas Health Science Center San Antonio
Certifications
- United States Medical Licensing Examination, 2012
Education
- Medical School: Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- Fellowship: Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas
- Fellowship: Medical Oncology, Hospital Conceicao, Porto Alegre, Brazil
- Residency: Internal Medicine, Santa Casa-Porto Alegre, RS, Brazil
- Doctorate: Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- Locations & Contact
-
Research & Publications
Research & Publications
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA,
Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to Treatment
Saleh M, Javadi S, Elsherif S, Patnana M, Sagebiel TL, Torres-Cabala C, Mattei J, Bhosale P, Faria SC.
The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019)
Chua V, Mattei J, Han A, Johnston L, LiPira K, Selig SM, Carvajal RD, Aplin AE, Patel SP.
View All Publications — Jane Mattei
-
Clinical Trials
Clinical Trials
No Clinical Trials